Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acid proteases are a class of enzymes that hydrolyze peptide bonds within proteins, functioning optimally at acidic pH, such as in the stomach (e.g., pepsin). They are crucial for the digestion and metabolism of dietary proteins in animals, and also participate in diverse cellular processes such as cell signaling, apoptosis, and immune regulation. Acid proteases are typically classified as endopeptidases due to their mode of action on internal peptide bonds. Dysfunction or aberrant activity of proteases is implicated in various diseases, making them important therapeutic targets and diagnostic markers in infection, cancer, inflammation, and other conditions. Drugs targeting proteases include inhibitory molecules used in treating specific diseases, and protease-activated prodrugs designed for selective activation in pathological tissues.
Competitive inhibition of protease active site; Irreversible inhibition by covalent modification; Protease-activated prodrugs: drugs activated by proteolytic cleavage at disease sites
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acid protease.